Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s):  FENC

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase 3 clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6. It has established Fennec HEARS, a single source program designed to connect PEDMARK patients.


TSX:FRX - Post by User

Comment by SharkRod812on Mar 25, 2004 9:05am
229 Views
Post# 7263393

RE: ?????????

RE: ?????????Dollarhunter, We dropped because there were daytraders that jumped in the water yesterday and were taken by surprise by the wall at $.65. They had to clear their positions the same day. While I too am surprised that this news did not generate enough volume to clear this mystery seller's position, I am not at all worried about it. AHX is building a launch pad, but this was not the launch. Good little NRs like this one will continue to come over the next two months. This will continue to build value in these shares and eat away the loose shares. The actual launch will probably be marked by the Exherin results and eventual US listing. Unlike, the mystery seller who is content to take 50% profit, I am a short term trader who looks for plays that make doubles as a minimum--and that is why I'm here. PS to the mystery seller--learn to clear your position in a controlled manner! If you want to ride your warrants up, don't kill the retail interest in the stock. Lucky for you, the Exherin results will probably save your stupid a$$.
Bullboard Posts